By performing FACS, we first showed that the IL-33 receptor IL1RL1 was constitutively expressed in BM cells from pediatric AML patients at diagnosis, whereas BM cells from healthy controls do not appear to express IL1RL1. The gene discussed is IL1RL1; the disease is acute myeloid leukemia.